NCT06471712: Clinical Study of 18F-LNC1007 Injection PET/CT

Summary

This study is a single-arm, single-center trial aimed at evaluating the pharmacokinetics, bio-distribution, dosimetry, and safety of 18F-LNC1007 injection in healthy volunteers and light tumor burden cancer patients, as defined by \<5 lesions on a conventional PET/CT done for clinical purposes and molecular imaging tumor volume of \<10ml. All participants must provide a signed consent form before enrolling in the trial. For each participant, the study duration will be about 3 weeks including 2 weeks' screening, 1 week of scanning and safety follow-up.

Timeline

Start: 2024-07-29
Primary completion: 2025-03-02
Completion: 2025-03-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	18F-LNC1007 Injection	Unknown	1 mbq/kg	Intravenous
Subject	18F-LNC1007 Injection	Unknown	3.7 mbq/kg	Intravenous

Indications

No indication recorded.